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Two-photon imaging of fluorescently labeled microglia in vivo provides a direct approach
to measure motility of microglial processes as a readout of microglial function that is
crucial in the context of neurodegenerative diseases, as well as to understand the
neuroinflammatory response to implanted substrates and brain-computer interfaces. In
this longitudinal study, we quantified surveilling and photodamage-directed microglial
processes motility in both acute and chronic cranial window preparations and compared
the motility under isoflurane and ketamine anesthesia to an awake condition in the
same animal. The isoflurane anesthesia increased the length of surveilling microglial
processes in both acute and chronic preparations, while ketamine increased the number
of microglial branches in acute preparation only. In chronic (but not acute) preparation,
the extension of microglial processes toward the laser-ablated microglial cell was faster
under isoflurane (but not ketamine) anesthesia than in awake mice, indicating distinct
effects of anesthetics and of preparation type. These data reveal potentiating effects of
isoflurane on microglial response to damage, and provide a framework for comparison
and optimal selection of experimental conditions for quantitative analysis of microglial
function using two-photon microscopy in vivo.
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INTRODUCTION
Microglia are highly dynamic immune cells of the central nervous system which have a wide range
of functions and play important roles in brain physiology and pathologies. Previous studies have
shown microglia make contacts with the vasculature, neurons, and astrocytes (Nimmerjahn et al.,
2005) and may promote dendritic spine formation (Parkhurst et al., 2013; Miyamoto et al., 2016).
The homeostatic activity of microglia involves protecting the brain from a barrage of frequently
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occurring small lesions, ranging from ruptured micro-capillaries
to dying cells releasing toxic content into tightly controlled
extracellular space (Kraft and Harry, 2011; Nayak et al., 2014).
This protective function relies on at least two distinct types of
motility of microglial processes: (i) surveilling motility, and (ii)
damage-directed motility.
The surveilling, a.k.a. resting, motility refers to surveillance
of the microglial cell’s immediate environment, which enables
timely detection of brain damage and pathogen infiltration
(Hanisch and Kettenmann, 2007). This surveilling motility
crucially depends on the membrane potential and requires
the constitutive hyperpolarizing activity of a specific type
of inwardly-rectifying potassium channel called TWIK-related
Halothane-Inhibited K+ channel, THIK-1 (Madry et al., 2018).
Resting motility also underlies microglia-synapse interactions,
during which microglial processes monitor synaptic function
and modify the “wiring” of neuronal circuits by strengthening
or eliminating individual synapses (Wake et al., 2009; Tremblay
et al., 2010; Schafer et al., 2012). Noteworthy, microglial
surveillance can be selective/directional in the sense that
microglial cells monitor and interact with neurons during
conditions of cerebral calcium reduction in the normal and
diseased brain (Eyo et al., 2015).
The damage-directed motility manifests as an extension, or
protrusion, of microglial processes toward a micro-lesion site
(Davalos et al., 2005; Nimmerjahn et al., 2005; Haynes et al.,
2006; Gyoneva et al., 2014). In contrast to surveillance, damage-
directedmotility of microglial processes does not require THIK-1
activity and hyperpolarized membrane potential but depends on
activation of the metabotropic purinergic receptor P2Y12 by ATP
released from the damaged cell(s) (Haynes et al., 2006). Other
types of purinergic receptors, including P2Y6, are involved in the
phagocytic activity of microglia at the site of damage (Hidetoshi
et al., 2012). Microglial response to brain damage is also regulated
by TAM (Tyro3, Axl, andMer) receptors (Fourgeaud et al., 2016).
These receptors play multiple functional roles as homeostatic
regulators in adult tissues and organ systems that are subject
to continuous challenge and renewal throughout life (Lemke,
2013) as well as in nervous system development and diseases
(Pierce and Keating, 2014).
General anesthesia is commonly used during in vivo imaging,
however, it may dramatically alter the function of brain
cells, including microglia. Known effects of anesthetics range
from suppressing neuronal firing and changing inter-cortical
synchronization to altering the morphology of glial processes
and affecting turnover rates of dendritic spines (Li et al.,
2010; Huh and Cho, 2013; Pryazhnikov et al., 2018). Recently,
Madry et al. (2018) have demonstrated that isoflurane and
related gaseous anesthetics strongly suppressed the motility of
microglial processes in acute brain slices. This suppression was
mediated by anesthetics’ blocking effect on THIK-1. The authors
demonstrated that both types of motility, non-directional and
damage-directed, were suppressed when isoflurane was applied
either in vivo prior to slice preparation or in situ by direct
exposure of slices.
Interestingly, suppression of microglial motility appears to be
restricted to gaseous anesthetics, because injectable anesthetics
such as urethane did not have such an effect (Madry et al.,
2018). It remains unknown, however, whether another injectable
anesthetic ketamine, which is widely used in mouse imaging
experiments, also affects non-directional and/or damage-directed
motility of microglial processes. Furthermore, since the motility-
suppressing effect of isoflurane was observed ex vivo by imaging
in brain slices, the question of whether this effect also occurs
in vivo remains unanswered and must be addressed using
microscopic analysis of the living brain. Besides anesthesia, other
factors can affect the outcome of in vivo experiments, such as the
interval between implantation of a cranial window and imaging
(hours for acute preparation vs. weeks for chronic preparation).
Here, we set out to address these issues by using in vivo
two-photon microscopy and directly compared the kinetics
of both resting and damage-directed motility of microglial
processes between awake and anesthetized states in acute and
chronic preparations.
MATERIALS AND METHODS
Animals
Seven 3–4 month-old male CX3CR1-GFP heterozygous
C57BL/6JCRL mice (B6.129P-Cx3cr1tm1Litt/J) (Jung
et al., 2000) (Jackson Laboratory; Stock No.005582) bred
at the DZNE (Magdeburg) animal facility were used in
this study. Since we were comparing different conditions
in the same animal, no randomization was performed.
The mice were housed individually under a fixed 12-h
light/dark cycle with food and water available ad libitum.
All animals were treated in strict accordance with ethical
animal research standards defined by the German law
and approved by the Ethical Committee on Animal
Health and Care of Saxony-Anhalt state, Germany (license
number: 42502-2-1346).
Surgical Procedures
Surgeries were performed as described previously (Senkov
et al., 2006; Holtmaat et al., 2009). Briefly, mice were sedated
in a chamber with isoflurane (Baxter, Germany) prior to
being stabilized in the stereotaxic apparatus (SR-6M, Narishige
Scientific Instrument Lab, Japan). Under stereotaxic head
fixation, isoflurane level was adjusted by using an isoflurane
vaporizer (Matrx VIP 3000, Midmark, USA) to 4% for
induction and 1.5–2% during surgery with 0.4 L/min O2,
while the depth of anesthesia was monitored by breathing
rate. During surgery, mice were placed on a heating blanket
connected to a temperature controller (ATC1000, World
Precision Instruments, USA) with the temperature maintained at
37◦C. An intraperitoneal (i.p.) injection of ketoprofen (5 mg/kg,
body weight) was done before surgery to prevent inflammation
and pain. In order to protect eyes from dehydration and
irritation, ophthalmic ointment was applied. After shaving the
hair and cleaning the scalp with 70% ethanol, a cutaneous
incision was made and a flap of skin, ∼ 1 cm2, covering the
skull over both hemispheres was removed. Then the surface
of the skull was cleaned with 10% povidone-iodine (Dynarex)
and 3% hydrogen peroxide solution (Sigma-Aldrich, Germany).
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A craniotomy (diameter ∼5mm, centered over midline) was
gently performed with a high-speed dental drill (Eickemeyer,
Germany) over the cortical area between bregma and lambda.
To prevent heat-induced damage of the underlying cortex,
drilling was interrupted, and sterile saline was applied on the
skull periodically. The craniotomy was then covered with a
circular glass coverslip (6mm diameter, Thermo Fisher Scientific,
Germany) and fixed with cyano-acrylic glue (Roti Coll-1,
CarlRoth, Germany). A custom-built 3D printed metal head-
plate (i.materialize, Belgium) was then implanted on the exposed
skull with glue and cemented with dental acrylic (Paladur,
Heraeus Kulzer, Germany). After all procedures, mice were kept
in a home cage with red-lamp warming for ∼30min until they
recovered from anesthesia.
Two-Photon in vivo Imaging
To address the differences of microglial morphology and
dynamics between awake and anesthetized conditions, we
performed the same imaging procedures in awake, isoflurane-
and ketamine-anesthetized conditions, respectively. Because we
were using the same animals for different conditions and the
anesthesia method was too transparent, we could not perform
blinding in this study. GFP-labeled microglial cells were imaged
by a custom-built two-photon microscope (Thorlabs, USA) with
a Ti: Sapphire pulsing laser (Chameleon, Coherent, USA) tuned
to 850 nm. A 20 X water immersion lens (1.00N.A.; Olympus,
Japan) at a zoom of 1.0 was used to acquire 512 × 512
pixels images with a field-of-view of 393 × 393µm throughout
all imaging sessions. Imaging and two-photon laser ablation
protocols were modified from previous studies (Davalos et al.,
2005; Nimmerjahn et al., 2005) and time-plan of experiments
is shown in Figure 1A. In order to avoid the effects of imaging
under one condition on subsequent imaging under another
condition, hemispheres were divided into quadrants and distinct
quadrants were used in different imaging sessions (as shown
in Figure 1A). For the first day after surgery, quadrants 1 and
3 were used for awake condition and isoflurane-anesthetized
condition, respectively. Quadrants 2 and 4 were used for second
awake condition and ketamine-anesthetized condition 2 days
after surgery, respectively. 1&3 (anterior) and 2&4 (posterior)
quadrants were counterbalanced between animals. For awake-
condition (1 day after surgery), mice were head-fixed under
the two-photon microscope using a Mobile HomeCage device
(Neurotar, Finland) in which head-fixed animals could freely
move a light cage around them. After 10min habituation in
the Mobile HomeCage, time-lapse imaging was performed for
33min (100 frames, 20 s interval) by recording z-stacks (6 optical
sections with a step size of 2µm) around 100–150µm below the
pial surface to monitor microglial morphology and dynamics in
the resting state. After acquiring images in the resting state, a
single cell laser ablation was achieved by focusing a two-photon
laser beam at a single microglia cell in the superficial layer of the
cortex to induce a highly precise and reproducible local injury.
The wavelength of the pulsed infrared laser was set to 780 nm
and the power was ∼150–200 mW at the target. The laser beam
was parked at the targeted cell by zooming in to an 18 × 18µm
field-of-view for ∼0.5 s to create a small highly localized photo-
damage. The final injury area was determined by a relatively
bright autofluorescent sphere (∼ 20µm diameter) around the
focal point. Immediately after the single cell laser ablation,
the same imaging procedure as in the resting state was taken.
Afterward, another laser ablation was performed at least 400µm
away from the first one. After imaging in awake mice, 2-h rest
was given to each animal before we started the imaging session
in the isoflurane-anesthetized condition. The same procedures
of imaging as in awake-condition were applied in the other
hemisphere, but the animal was head-fixed using a custom-made
frame with a heating pad to keep body temperature constant,
and anesthetized by 1.5% isoflurane during the imaging, which
started 10min after anesthesia induction, i.e., with the same
interval as the habituation period in awake condition. On the
next day (2 days after surgery), we repeated awake-condition
imaging in another quadrant as described above. After 2-h
rest, animals were intraperitoneally injected with ketamine (90
mg/kg body weight) and xylazine (18 mg/kg body weight) in
0.9% NaCl solution and placed in a head fixation frame in the
same manner as used for imaging in isoflurane-anesthetized
condition. During the imaging session, ketamine was added
approximately every 35min tomaintain anesthesia between basal
recording and after-damage recordings. The imaging procedure
in ketamine-anesthetized condition was the same as for the other
two conditions. All imaging sessions under different conditions
were repeated at 4 months post-surgery, i.e., after the cranial
window reached a chronic (steady-state) condition and the only
difference was the interval between awake 1 and awake 2 imaging
sessions, which was 7 days instead of 1 day (Figure 1A).
Analysis of Microglia Dynamics in
Surveillance and Photodamage-Directed
State
Before the quantitative analysis, the movement artifacts in
obtained images (100 frames and 6 z-stacks) were neutralized
using ImageJ software (Schindelin et al., 2012). Six sequential
z-stacks of images were first subjected to the ImageJ plug-in
StackReg/TurboReg with “rigid body” mode and the aligned z-
stacks were maximally projected to a single image at every frame
(Thévenaz et al., 1998). The projected images aligned along z-axis
were then subjected to the same alignment processing along the
time-axis (100 frames). Briefly, every 10 frames were averaged
to improve the signal-to-noise ratio and compared between the
first 10 frames (0–3min) and the last 10 frames (30–33min).
Each microglia process was 2-dimensionally traced by the Fiji
plug-in Simple Neurite Tracer (Longair et al., 2011). Tracing of
microglial processes was done by an experimenter blind to the
experimental conditions. The longest processes stemming from
the microglial cell body were traced as the primary processes,
and the arborized processes from each primary process were
traced to include the secondary, but not tertiary or further,
branches. We calculated the average length and number of
primary processes per microglia, the average length of arborized
primary processes per microglia, the average terminal number in
the arborized primary processes, the total length of the primary
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FIGURE 1 | A scheme of experiments. (A) Schedules of in vivo two-photon imaging of microglia in awake, isoflurane- and ketamine-anesthetized mice. For each
condition, imaging is done in a resting and photodamage state. The same imaging protocols are applied acutely, i.e., 1–2 days after the surgery (5 animals), and/or in
chronically implanted mice (around 4 months after the surgery, 4 animals). (B) Imaging examples in the resting and photodamage conditions. (B1) Z-stacks (6 images)
are acquired at a 20 s interval for 33min, generating 100 time frames. (B2) Two-dimensional tracing of microglia processes with 30min interval in the resting state
(scale bar, 10µm). (B3) Analysis of microglia response to photodamage. A red arrowhead indicates the center of damage induced by the high-power laser stimulation
(scale bar, 50µm).
+ secondary (defined as “all”) processes and the total numbers
of the all processes per microglia. Each process was traced
twice, with 30min interval, and the changes were qualified as
“Disappear,” “Decrease,” “No change,” “Increase” and “Appear”
with respect to each primary process, arborized process, and
all processes. The parameters were measured and averaged
from at least 3 microglial cells per animal. Our quantification
method is similarly based on the manual tracing of processes
and provides the terminal number that is comparable to the
previously reported value by other researchers (on average, 18
vs. 20 in control conditions; Nimmerjahn et al., 2005). Although
our measurements resulted in a shorter total length of processes
than previously reported (226 vs. 400µm; Nimmerjahn et al.,
2005), probably due to differences in the imaging conditions and
the criteria used for tracing of processes, we can compare the
lengths of processes among different conditions within our study.
The dynamics of microglial processes is similar for our and the
previous work (same fractions of processes which were increased
or decreased, resulting in constant total length), suggesting the
validity of our measurements.
For the analysis of damage-directed response, the
quantification of microglial process velocity was based on
the intensity of microglia around damage spot, which is a
method similar to Davalos et al. (2005) and rendered the
comparable value (1.6 vs. 1.2 µm/min) in control conditions. In
detail, as a method to calculate the velocity of damage-directed
process motility, the center of each ROI was set to the microglial
processes apparent attraction point. Using the Radial Profile
Extended ImageJ plugin, the normalized intensity profiles for
R ≤ 75µm for each time point were calculated. A set of these
100 radial profiles was converted into grayscale images and
3D height images using a custom-built R script. Microglial
processes were readily visible as a distinct stripe on the 2D
images and as a ridge on the 3D images. Using the 2D image, a
line ROI was drawn along the path of the microglial processes
and their projections onto time (1t) and distance to the damage
(1D) axes. Velocity was measured as 1D/1t. Additionally,
in order to get a better visualization of the events happening
during the microglial activity, a stack was converted into a
color-coded image, where each time point was coded with its
own color (Figure 5A). Since the velocity of damage-directed
process motility is a crucial parameter in such studies, we
additionally applied another—more objective—method by
using the Sholl analysis applied to the aligned z-projection
images (100 frames) to measure the advance of microglia
process toward the injury spot. The measurement was done
from the time when the microglia process started to migrate
toward the injury center to the time when the microglia reached
the injury spot. To reduce the noise and background and
specifically detect the dynamics of the microglia process, the
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Gaussian filter (σ = 0.5) and background subtraction (10 px)
was applied to every image and the bright signals of microglia
soma and injury spot artifact were deleted by the masked
images derived from Analyze Particles calculation (>50 px,
default threshold, at the first frame). Then the process frontier
was measured by detecting the peak intensity of microglia
processes on the circumference at the distance from the injury
spot. The auxiliary line was drawn to enhance the visible
frontier in some images with a lower signal-to-noise ratio. The
distance of peak intensity was plotted along the time and the
regression curve was calculated as a linear line with the high
correlation coefficient between the observed and predicted
values (R2 > 0.9). The slope was used as the calculated velocity
(Supplementary Figure 3A). Finally, we defined the injury size
as the size of the relatively bright autofluorescent sphere around
the focal point immediately after laser ablation and the activation
area was measured according to the radius of the apparent
microglia process frontier starting to approach the center of the
photodamage (Supplementary Figure 4). Statistical analysis was
performed using XLSTAT (STATCON, Germany), as described
in Results.
RESULTS
To analyze microglia functions in vivo, we implanted a glass-
covered cranial window above the cortical region between
bregma and lambda, including the retrosplenial cortex, which is
one of the cortical areas critically involved in spatial navigation
that is affected at early stages of Alzheimer’s disease. Two-
photon imaging was performed either in acute preparation, i.e.,
on the first and second days after the window implantation
(5 mice), or in chronic preparation, i.e., 4 months after the
implantation (3 of the 5 acutely imaged mice and 1 new mouse)
(Figure 1). The effects of two commonly used anesthetics,
FIGURE 2 | Dynamics of microglial processes in awake, isoflurane (Iso)- and ketamine (Keta)-anesthetized mice in acute experiments (5 animals). Schematic drawing
of microglial processes (represented in color-matching mode): primary processes (A1), arborized processes (B1) and all processes (C1). Quantification of the average
or total length and the total terminal number per primary process (A2,A3), arborized process (B2,B3) and all processes (C2,C3). The dots show individual mean
values ± SEMs per animal, the values from the same animal are connected by lines (B2,B3,C2,C3). White and dotted bars show means ± SEMs for all animals at
time = 0 and 30min. Processes are categorized according to morphological changes, such as “Disappear,” “Decrease,” “No change,” “Increase,” or “Appear”
(A4,B4,C4). *p < 0.05, n.s., non-significant, one-way RM nested ANOVA, Newman-Keuls post-hoc test for A2–C2; Kruskal-Wallis test with Conover-Iman multiple
comparison tests for A3–C3 and A4–C4.
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isoflurane and ketamine, were analyzed. The longitudinal design
allowed a within-animal comparison of microglial morphology
and motility in awake vs. anesthetized conditions on the same
day, with a 2-h interval between sessions. Each session included
imaging of microglia at the resting state and after photodamage
induced at two spatially separated sites by laser ablation of a single
microglia cell (Figure 1), as the only unequivocally defined target
in our experimental settings.
Analysis of Structure and Motility of
Microglia at the Surveilling State
To characterize microglia at the surveilling state, we traced
their processes and compared the length and number of
primary microglial processes (the longest processes originating
from the soma, without secondary, tertiary, etc. branches;
Figure 2A1), as well as the length and number of terminals of
arborized processes, i.e., including secondary but not tertiary
or further branches (Figure 2B1). Then, we analyzed the total
length and number of terminals of all processes per cell
(Figure 2C1). The same cells were traced twice, at time 0
and in 30min (white and dotted columns, respectively, in
Figures 2, 3) to quantify the cell motility. A representative
movie of microglia at the surveilling state is shown in
Supplementary Material.
In acute preparation, we found a difference between
measurements done in awake and anesthetized conditions (using
one-way repeated measures (RM) nested ANOVA for the length
of processes and Kruskal-Wallis test for the number of processes
and the change of the categories), with the type of anesthesia
affecting the microglia processes in different ways (Table 1).
During isoflurane anesthesia on day 1, microglial primary and
secondary processes were significantly elongated compared to
the awake condition. This was evident in terms of the average
length of primary processes (p = 0.038; Figure 2A2) and the
FIGURE 3 | Dynamics of microglial processes in awake, isoflurane (Iso)- and ketamine (Keta)-anesthetized mice in chronic experiments (4 animals). Schematic
drawings of microglial processes to be analyzed (in colors): primary processes (A1), arborized processes (B1), and all processes (C1). Quantification of average or
total length and total terminal number of primary processes (A2,A3), arborized processes (B2,B3) and all processes (C2,C3). The dots show individual mean values
± SEMs per animal, the values from the same animal are connected by lines (B2,B3,C2,C3). White and dotted bars show means ± SEMs for all animals at time = 0
and 30min. Processes are categorized according to morphological changes, such as “Disappear,” “Decrease,” “No change,” “Increase,” or “Appear” (A4,B4,C4). *p
< 0.05, n.s., non-significant, one-way RM nested ANOVA, Newman-Keuls post-hoc test for A2–C2; Kruskal-Wallis test with Conover-Iman multiple comparison tests
for A3–C3 and A4–C4.
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TABLE 1 | Summary of results: “↑” and “↓” means a significant increase and
decrease, respectively, p < 0.05.
Motility type Acute cranial
window
Chronic cranial
window
Isoflurane Ketamine Isoflurane Ketamine
Microglial
surveilling
Length ↑ ↑
Ramification ↑
Processes’
disappearance
↓
Damage- directed Velocity ↑
Activation area
average length of arborized processes (p = 0.003; Figure 2B2). A
post-hoc pairwise comparison showed an increase in the average
length of primary and arborized processes in the isoflurane group
(17.2 ± 1.7 and 26.3 ± 3.9µm, respectively) as compared to
awake mice on day 1 (13.7± 0.8 and 18.9± 1.0µm, respectively;
Figures 2A2,B2). In contrast, during ketamine anesthesia on
day 2, the average length of processes was unchanged but the
number of total processes was increased compared to the awake
condition (total number of terminals of all processes (p < 0.001;
Figure 2C3). Specifically, ketamine increased the total terminal
number of all processes (13.4 ± 0.9 vs. 16.8 ± 1.7; Figure 2C3).
Additionally, a difference between awake mice imaged on days
1 and 2 was found in terms of process lengths (primary: 13.7
± 0.8 and 16.8 ± 1.1µm, respectively, Figure 2A2; arborized:
18.9 ± 1.0 and 26.6 ± 2.5µm, respectively, Figure 2B2; all
processes: 123.8 ± 14.7 and 161.1 ± 11.7µm, respectively,
Figure 2C2), suggesting that anesthetized condition, as well as
imaging period, differentially affect the microglia processes in
acute preparation.
When we followed microglia processes over a 30-min interval,
we did not find any differences in the process length between
awake and anesthetized conditions (Supplementary Figure 1).
However, a closer inspection of process dynamics revealed that
the isoflurane anesthesia affected the turnover of microglia
processes, with fewer primary processes disappearing and more
primary processes decreasing under isoflurane anesthesia than in
awakemice on day 1, while the appearance and elongation of new
processes were not affected (Figures 2A4–C4).
In chronic preparation, we again found a significant difference
between the awake and isoflurane-anesthetized conditions in
terms of the average length of primary processes (p = 0.008;
Figure 3A2) and the average length of arborized processes (p =
0.039; Figure 3B2; one-way RM nested ANOVA). In line with
acute experiments, we observed an increase in the length of
primary and arborized processes in isoflurane-anesthetized (24.4
± 2.1 and 48.6± 4.1µm, respectively) vs. awake conditions (19.3
± 1.6 and 35.9 ± 4.2µm, respectively) in chronic experiments
(Figures 3A2,B2). No difference in other structural parameters
and motility was detected (Figure 3).
Analysis of acute vs. chronic preparation revealed the effect of
an interaction between Condition and Preparation on the total
length of all processes (p = 0.017; Supplementary Table 2). We
observed an increase in the total length in chronic preparation
(226.7 ± 17.2µm) vs. acute preparation in the first awake
condition (123.8 ± 14.7µm; Figure 4), suggesting that in the
chronic preparation microglia are more in the surveilling rather
than activated state in contrast to the acute preparation. Statistical
summary for comparisons of parameters at the resting state is
displayed in Supplementary Table 1.
Analysis of Damage-Directed Microglia
Response
To study the damage-directed microglia response, we induced
photoablation of a single microglial cell. Laser irradiation
of microglia soma resulted in a collapse of the microglia
processes. The site of damage remained visible as a fluorescent
spot to which other microglial cells extended their processes,
forming a ring-like structure (Figure 5A1). A representative
movie of microglial response to a photodamage is shown
in Supplementary Material. Measuring the intensity of
fluorescence as a function of distance to the damage center
in the time series of 3D images (Figures 5A1–3), revealed a
peak (at the position of the ring) that was approaching the
damage site with a constant velocity. One-way RM nested
ANOVA revealed a difference between four conditions in
terms of velocity in both acute and chronic preparations (p =
0.001 and p = 0.005, respectively; Figures 5B1, 2). In acute
experiments, there was no effect of anesthetics, but there was
a significant difference between days 1 and 2 under awake
conditions (1.7 ± 0.4 and 2.5 ± 0.2 µm/min, respectively). In
chronic experiments, the velocity was increased under isoflurane
anesthesia (2.6 ± 0.4 µm/min) compared to awake condition
(1.6 ± 0.1 µm/min) on day 1. Direct comparison between
acute and chronic preparation revealed that a faster process
velocity was seen in isoflurane condition in chronic than in
acute preparations (Figure 5C), suggesting that the isoflurane
differently affect microglia response in these experimental
conditions. A slightly different method for measurements of
velocity was based on the determination (for each frame) of the
distance where the maximal fluorescence intensity was observed
(Supplementary Figures 3A1,A2). Then a linear regression was
used to determine the velocity (Supplementary Figure 3A3).
Noteworthy, the linear regression provided an excellent fit
to data (R2 > 0.9) and the results obtained by this method
(Supplementary Figures 3B1–2, C1–2) perfectly matched the
outcome of the aforementioned analysis of velocity.
Additional analysis of damage-directed microglia behavior
by measuring the cumulative intensity of microglial processes
in the area surrounding the photodamage site revealed that
at some sites there was a biphasic response: immediately after
photodamage, microglia first moved away from the damage,
i.e., was repelled from, and then attracted to the damage
site (Supplementary Figure 2). Hence, as another measure of
microglial activation, we estimated the maximal size of the
area surrounded by microglia processes in a ring-like manner
at the moment when the frontier of microglia processes
starts to advance toward the damage site. There was large
variability in this activation area in acute experiments (p =
0.006; Supplementary Figure 4A). On average, the profile of the
mean activation area in all experimental groups mirrored that
Frontiers in Neuroscience | www.frontiersin.org 7 May 2019 | Volume 13 | Article 421
Sun et al. Two-Photon Imaging of Microglia
FIGURE 4 | Dynamics of microglial processes in acute vs. chronic preparations. (A) Representative images of microglia from acute and chronic preparations,
respectively (scale bar, 10µm). (B) Comparison of total length of all microglial process between acute and chronic preparation in all conditions. The dots show
individual mean values ± SEMs per animal, the values from the same animal are connected by lines. White and dotted bars show means ± SEMs for all animals in
acute and chronic preparations. *p < 0.05, n.s., non-significant, the Newman-Keuls post-hoc test.
of mean velocity (Figure 5B). Correlation analysis of velocity
and activation area within individual experiments revealed a
highly significant correlation between these parameters both in
acute experiments (Spearman r = −0.576, p = 0.00014), and
in chronic experiments (Spearman r = −0.371, p = 0.043),
particularly under isoflurane anesthesia (Spearman r = −0.526,
p = 0.030). To find out whether the velocity also depended on
other parameters in photodamage experiments, we performed
correlation analysis for the damage area, estimated as the
fluorescent area at the site of laser irradiation, the number
of microglia cells adjacent to the damage site and the mean
distance between their somata and the damage site. There were
no significant correlations between these parameters and velocity
in acute and chronic experiments (Supplementary Figure 4).
Statistical summary for comparisons of parameters in response
to a photodamage is displayed in Supplementary Table 3.
Taken together, these data demonstrate that morphology
and motility of microglia in vivo are strongly affected by
such experimental conditions as the preparation type (acute
vs. chronic preparation) and state of consciousness (awake vs.
ketamine-anesthetized vs. isoflurane-anesthetized).
DISCUSSION
The main findings of this study are the significant effects of
both the preparation type and the anesthetics on microglial
morphology, motility, and response to damage. Notably, the
potentiating effect of isoflurane on microglial motility that we
observed using in vivo imaging is in sharp constant with the
motility-suppressing effect of isoflurane observed previously
using ex vivo and in vitro imaging (Madry et al., 2018), once again
highlighting the need for caution when extrapolating the results
of ex vivo/in vitro experiments to in vivo conditions. However, we
acknowledge that the effect of anesthesia depends on the readout
used for analysis.
In the chronic preparation, where the cranial window
was implanted 4 months prior to imaging, isoflurane (but
not ketamine) significantly increased the length of microglial
processes and accelerated their damage-directed motility. These
effects are consistent with the notion that isoflurane enhances
the homeostatic microglial activity and reinforces the “resting-
state” phenotype of microglia characterized by highly-ramified
morphology and rapid reaction to microscale lesions. Ketamine
anesthesia had no effect on the parameters quantified in this
study (Table 1), suggesting that this injectable anesthetic may be
more suitable than gaseous ones (such as isoflurane) for chronic
microglia imaging.
In acute preparation, isoflurane also induced significant
elongation of microglial processes like in chronic preparation;
however, isoflurane did not accelerate damage-directed
microglial motility (Table 1). It seems plausible to suggest
that in the acute preparation the strong effects of post-surgical
inflammation on microglial motility and morphology may have
masked the effect of isoflurane on damage-directed motility.
Ketamine significantly increased microglial ramification under
acute conditions, in contrast to chronic conditions where
ketamine had no effect (Table 1). These findings indicate that
putative post-surgical inflammation occurring during the first
days after acute window implantation can have a dramatic effect
on microglial motility and morphology, comparable to or even
more prominent than the effects of anesthesia.
Interestingly, certain time-dependent changes observed
in the acute preparation apparently resulted in a variety of
alterations in microglial morphology and dynamics. Indeed,
compared to post-surgical day 1, on day 2 the microglial
processes were significantly elongated (Figures 2A2–C2),
the damage-directed motility was significantly accelerated
(Figure 5B1), and the activation area surrounding the
damaged site was reduced (Supplementary Figure 3B2).
While elucidation of the mechanisms underlying the observed
time-dependent changes will require further studies, these
changes are most likely related to a gradual onset of
post-surgical inflammation.
Our findings, therefore, highlight the need for caution in
interpreting data obtained with acute cranial windows (i.e.,
windows freshly prepared on the same day or 1–2 days prior
to imaging). In sharp contrast to acute preparation, in chronic
cranial windows, none of the quantified microglial parameters
changed significantly between first and second imaging sessions
(Figures 3A3–C3, Figure 5B2, and Supplementary Figure 3C).
This is consistent with a relative stability of microglial morpho-
functional parameters in chronic preparation, and is also in
line with the conclusion of a previous study (Dorand et al.,
2014) that a resting period of at least 1–3 weeks is preferable
before collecting experimental data on microglia in order to
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FIGURE 5 | 3D analysis of the photodamage-directed response of microglia. (A1) In order to get a better visualization of the events happening during the microglia
activity, a time stack is converted into a color-coded image using a standard Fiji (ImageJ) function, where each time point is coded with its own color (scale bar,
50µm). (A2) Sholl-analysis of fluorescence intensity as a function of distance from the damage site with colors matching those in (A1). (A3) The three-dimensional
plot to show the advance of microglial processes to the damage site. (A4) The same data as in (A3) are shown as a gray-coded image, with a line used to calculate
the velocity. B. Quantification of microglial process velocity in acute (B1) and chronic (B2) experiments. (C) Comparison of microglial process velocity between acute
and chronic experiments. The dots show individual mean values ± SEMs per animal, the values from the same animal are connected by lines (B1,B2,C). Bars show
means ± SEMs values for all animals. *p < 0.05, **p < 0.01, ***p < 0.001, n.s., non-significant, the Newman-Keuls post-hoc test, 5 animals for acute and 4 animals
for chronic experiments.
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minimize local and systemic host responses toward potential
damage resulting from the surgical procedure. As a valuable
alternative preparation, a thinned-skull window has been widely
used for imaging microglia in vivo, both for acute experiments
(Wake et al., 2009; Liu et al., 2010) and chronic experiments
(after implanting a coverslip on top of the thinned bone: Marker
et al., 2010; Yang et al., 2010). This type of preparation is
believed to minimize the inflammatory background unavoidable
in cranial window preparations. However, the thinned-skull
approach has limitations for deep imaging studies, and studies
requiring a large visual field or direct access to brain
parenchyma for drug or virus delivery. Therefore, our results
outline optimal conditions for acute and chronic imaging in
applications that may benefit from cranial window preparation
due to a necessity to perform deep high-resolution imaging,
for instance of interaction between microglia processes and
presynaptic boutons or postsynaptic spines, or reproducible,
stereotypical induction of the laser injury with a fixed set
of parameters.
An alternative explanation for significant alterations in
microglia dynamics observed on day 2 in acute preparation is
that the effect of isoflurane administered on day 1 did not subside
completely by the time when the same animal was re-imaged
in awake conditions (day 2). A recent study has demonstrated
that isoflurane anesthesia promoted phosphorylation of TrkB
receptors in several brain regions (Antila et al., 2017). Although
the phosphorylation per se was transient and subsided in
15min (Antila et al., 2017), the downstream effects of TrkB
phosphorylation may be much more long-lasting, as reported
for clinical effects of isoflurane (Langer et al., 1985, 1995;
Weeks et al., 2013). With the present design of the experiment,
we intended to avoid possible long-lasting effects of ketamine
anesthesia done on day 1 on subsequent imaging on day
2. However, we acknowledge that this approach imposes
some limitations in the interpretation of our data due to
the possible effect of previous exposures to anesthesia and/or
laser injuries may affect the readout on the subsequent
imaging day.
There are multiple mechanisms by which anesthetics (both
volatile and injectable) could affect microglial dynamics. One
of ketamine’s best-characterized mechanisms of action is via
inhibition of NMDA-type glutamate receptors, which are also
expressed by microglial cells (Kaindl et al., 2008; Murugan et al.,
2013). Furthermore, ketamine can exert its action via other
receptors and/or signaling pathways, including brain-derived
neurotrophic factor, which is considered to be a key player
in ketamine’s antidepressant action (Björkholm and Monteggia,
2016) as well as TLR3, NO and HCN1 (Mei et al., 2011;
Sleigh et al., 2014). Considering ketamine’s well-documented
potentiating effect on dendritic spine formation rate (Li et al.,
2010; Phoumthipphavong et al., 2016; Pryazhnikov et al.,
2018), and the role of activated microglia in spine elimination
under pathological conditions (Bisht et al., 2016, 2018), it
is reasonable to hypothesize that ketamine’s spine-promoting
effect may, at least in part, be due to ketamine suppressing
microglial activation. Indeed, our results demonstrate that, at
least in acute preparation, ketamine increased ramification of
microglial processes. The fact that this effect was not seen
in chronic conditions suggests that the influence of ketamine
on microglia is enhanced by a global stressor (i.e., surgery),
while local damage did not result in a detectable influence
of ketamine.
Like ketamine, isoflurane has been reported to affect microglia
via several distinct mechanisms, involving modulation of NMDA
receptors (which are inhibited by isoflurane, albeit less potently
than by ketamine) as well as the TLR4/NF-kB pathway and
GABAA receptors (Brosnan, 2011; Xiang et al., 2014; Sun et al.,
2015). Changes in microglia behavior under isoflurane anesthesia
are noteworthy in the context of the isoflurane-induced elevation
in TrkB signaling (Antila et al., 2017) that might reflect
the microglial release of BDNF or matrix metalloproteinases
converting pro-BDNF to mature BDNF. In a recent study
(Szalay et al., 2016), longitudinal two-photon imaging was
performed in isoflurane-anesthetized mice to demonstrate a
protective role of microglia in a model of stroke. While the
authors argue that the low-level isoflurane (0.8–1.1%) used
during imaging should not influence the observed detrimental
effect of microglia removal on neuronal activity, it is noteworthy
that a slightly higher level of isoflurane (1.5%) used during
imaging in the current study, did have a significant effect
on microglial process morphology, in both acute and chronic
preparations (see Table 1).
In conclusion, considering the reproducibility and quality
of data obtained with two-photon imaging of microglia in
awake mice with a chronically implanted transcranial window,
we recommend this approach for the studies of microglia
morphology and function in vivo in adult animals. Obviously,
this approach allows to avoid the confounding effects of
anesthetics and transient inflammation induced by window
implantation. Because we did not detect any differences between
awake and ketamine-anesthetized mice with a chronically
implanted transcranial window, the ketamine anesthesia could
be a useful alternative to awake imaging, at least for analysis
of parameters quantified in the present studies. However,
other experimental factors, such as mouse genotype or global
experimental stressors, may interact with chronic inflammation
and ketamine in a yet unknown fashion and unpredictably
bias the outcome; thus, microscopic imaging experiments in
awake mice still should be preferred. Apart from the Mobile
Home Cage used in the current study, alternative methods
have been employed for imaging of head-fixed awake mice
(Rangroo Thrane et al., 2012; Akiyoshi et al., 2018). If a
laboratory is not equipped with a head-fixation device that allows
awake imaging, then ketamine anesthesia could be preferable
to isoflurane.
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